FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new derivatives if azaindole of the formula (I)
or its pharmaceutically acceptable salts wherein the formula is taken among the group consisting of , , and and wherein each among R1, R2, R3 and R4 is taken independently among the group consisting of hydrogen atom (H), (C1-C6)-alkyl, (C2-C6)-alkenyl, halogen atom, cyano-group (CN), phenyl, nitro-group, -OC(O)R15, -C(O)R15, -C(O)OR16, -OR19, -SR20 and NR21R22 wherein R15 is taken independently among the group including hydrogen atom (H),(C1-C6)-alkyl and (C2-C6)-alkenyl; each among R16, R19 and R0 is taken independently among the group including hydrogen atom (H), (C1-C6)-alkyl or (C1-C6)-alkyl substituted with from 1 to 3 halogen atoms; each among R21 and R22 is taken among the group including hydrogen atom(H), hydroxy-group (OH), (C1-C6)-alkyl; R5 represents the group (O)m wherein m = 0 or 1; n = 1 or 2; R6 is taken among the group including hydrogen atom (H), (C1-C6)-alkyl, -C(O)R24 and -C(O)OR5 under condition that carbon atoms comprising carbon-carbon double bond of indicated (C3-C6)-alkenyl are not the addition point to nitrogen atom to which R6 is joined; R24 is taken among the group consisting of hydrogen atom (H), and (C1-C6)-alkyl; R25 represents (C1-C6)-alkyl; each among R7, R8, R9, R10, R11, R12, R13 and R14 is taken independently among the group including hydrogen atom (H) and (C1-C6)-alkyl; Ar is taken among the group including:
, and . Compounds of the formula (I) inhibit HIV-1 that allows proposing their applying in medicine.
EFFECT: valuable medicinal and antiviral properties of compounds.
22 cl, 13 sch, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
AZAINDOLEOXOACETIC DERIVATIVES OF PIPERAZINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2303038C2 |
METHOD FOR INHIBITING TUMOR CELLS WITH NEW DERIVATIVES OF 3-TRIFLUOROMETHYLQUINOXALINE 1,4-DIOXIDE | 2020 |
|
RU2746395C1 |
DERIVATIVES OF 1,4-DIOXIDE OF QUINOXALINE-2-CARBONITRILE INHIBITING TUMOUR CELLS GROWTH | 2016 |
|
RU2640304C1 |
ANTAGONISTS OF CHEMOKINE RECEPTORS | 2013 |
|
RU2646762C2 |
SEMI-SYNTHETIC DERIVATIVES OF HELIOMYCIN INHIBITING TUMOR GROWTH | 2016 |
|
RU2644780C2 |
DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD | 2000 |
|
RU2293728C2 |
DIAZOLE LACTAMS | 2013 |
|
RU2666730C2 |
ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF FOR INHIBITING NOREPINEPHRINE, DOPAMINE AND SEROTONIN REUPTAKE | 2005 |
|
RU2388751C2 |
4-PHENYL-SUBSTITUTED TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT BASED ON THEREOF | 2001 |
|
RU2301808C2 |
MULTITARGET INHIBITORS OF TUMOUR GROWTH BASED ON LINEAR HETEROARENE ANTHRACENEDIONES | 2013 |
|
RU2527273C1 |
Authors
Dates
2005-08-27—Published
2001-01-19—Filed